Significant Ownership of Medtronic plc

Signature - Title
/s/ Brian Sandstrom - Brian Sandstrom/VP, Chief Corporate and Securities Counsel
Location
Galway
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Medtronic plc.

Follow Filing Activity

Follow Medtronic plc and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of Medtronic plc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MMED MiniMed Group, Inc. Common Stock, par value $0.01 per share 90% $3,637,984,078 252,813,348 Medtronic plc 31 Mar 2026
OBIO Orchestra BioMed Holdings, Inc. Common Stock, Par Value $0.0001 Per Share 18% $41,826,294 +$17,470,292 10,078,625 +72% Medtronic plc 31 Dec 2025
AVR Anteris Technologies Global Corp. Common Stock 16% $78,107,474 15,652,173 Medtronic plc 22 Jan 2026

Schedules 13D/G Reported by Medtronic plc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .